PERRIGO EV/EBIT PRGO

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2014.

Today, Oct 23, 2026: 3.7×
9-year median: 25.5×
Against its 9-year history: 7th; percentile: 0 is its lowest day, 100 its highest
9-year range: 2.9× to 228×
Peer median: 10.5×

PERRIGO's EV/EBIT is 3.7× as of Oct 23, 2026.

That is below its 9-year median of 25.5×, lower than on 93% of days in the last 9 years.

Over that time it ranged from 2.9× in Mar 2026 to 228× in Aug 2024.

The median for 10 large drugmakers of a similar size is 10.5×.

EV/EBIT over time

median 25.5×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.7×	2.9×	18.9×
2025	18.3×	17.7×	134×
2024	133×	39.4×	228×
2023	39.6×	37.0×	94.1×
2022	75.9×	12.6×	75.9×
2021	14.3×	13.4×	90.2×
2020	23.6×	23.3×	34.8×
2019	31.4×	13.5×	32.6×
2018	13.0×	12.4×	23.1×
2017	n/m a value too high to mean anything
2016	22.7×	22.7×	34.5×
2015	33.8×	33.7×	46.4×
2014	44.9×	36.8×	45.4×

Against its peers

Companies in Drug Manufacturers - General nearest PERRIGO's size, closest first, today.

Company	EV/EBIT
PRGOPERRIGO	3.7×
PBHPrestige Consumer Healthcare	14.5×
HRMYHarmony Biosciences	6.9×
NRIXNurix Therapeutics	7.1×
ANIPANI Pharmaceuticals	10.5×
PAHCPhibro Animal Health	11.7×
ANABAnaptysbio	n/m
PCRXPacira BioSciences	7.6×
OGNOrganon	9.5×
LQDALiquidia	21.7×
ARQTArcutis Biotherapeutics	111×
Peer median	10.5×

Where PERRIGO ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on PERRIGO

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.